Table 1.
Date of culture | Site of isolation | Microorganism |
---|---|---|
Patient A | ||
8/13 | BAL | Serratia marcescens |
Klebsiella pneumoniae | ||
8/21 | Blood | Pseudomonas aeruginosa |
8/24 | Peri-rectal swab | VRE |
9/5 | BAL | Stenotrophomonas maltophilia (MDRO) |
9/7 | Blood | Enterococcus faecalis |
Enterococcus faecium (VRE) | ||
Methicillin-resistant Staphylococcus aureus | ||
Urine | Candida krusei | |
9/16 | Urine | Candida parapsilosis |
10/7 | Cohort day | |
No further positive cultures | ||
10/28 | Death | |
Patient B | ||
5/31 | Peritoneal fluid | Candida albicans |
6/8 | Peri-rectal swab | VRE |
Blood | E. faecium (VRE) | |
6/25 | Wound | K. oxytoca (MDRO) |
7/10 | Blood | S. epidermidis |
7/16 | Peritoneal fluid | C. glabrata |
S. maltophilia (MDRO) | ||
8/12 | Peritoneal fluid | Aeromonas hydrophilia (MDRO) |
8/21 | Peritoneal fluid | C. parapsilosis |
10/7 | Cohort day | |
10/21 | Peritoneal fluid | P. aeruginosa |
11/17 | Death | |
Patient C | ||
9/14 | Peri-rectal swab | VRE |
9/20 | Abdominal abscess | C. albicans |
Citrobacter freundii (MDRO) | ||
K. pneumoniae (MDRO, KPC) | ||
9/24 | Blood | E. faecalis |
10/7 | Cohort day | |
10/14 | Peritoneal fluid | P. aeruginosa |
10/16 | Discharge from ICU | |
10/28 | Discharge to home | |
Patient D | ||
9/28 | Blood | A. hydrophilia (MDRO) |
Escherichia coli | ||
9/30 | Peritoneal fluid | K. oxytoca |
Proteus mirabilis | ||
E. faecium (VRE) | ||
10/7 | Cohort day | |
10/15 | Discharge from ICU | |
11/1 | Sputum | P. aeruginosa (MDRO) |
11/6 | Peritoneal fluid | Providencia rettgeri |
5/3 | Discharge to home | |
Patient E | ||
8/17 | Blood | C. glabrata |
8/22 | Wound abscess | C. albicans |
8/24 | Peri-rectal swab | VRE |
9/12 | Peritoneal fluid | K. pneumoniae (MDRO) |
Enterobacter cloacae | ||
9/24 | BAL | E. faecium (VRE) |
9/26 | Pseudocyst aspirate | P. mirabilis (MDRO) |
10/7 | Cohort day | |
10/10 | Blood | C. parapsilosis |
10/16 | Peritoneal fluid | C. freundii (MDRO) |
P. aeruginosa (MDRO) | ||
E. faecium | ||
11/30 | Death | |
Patient F | ||
9/14 | Urine | E. coli |
9/23 | Urine | C. glabrata |
9/28 | Peri-rectal | K. oxytoca (MDRO) |
10/7 | Cohort day | |
10/8 | BAL | K. oxytoca |
11/3 | Discharge from ICU | |
11/5 | Urine | C. freundii (MDRO) |
11/24 | Discharge to home |
BAL=bronchoalveolar lavage fluid; ICU=intensive care unit; KPC=cCarbenapenase-producing Klebsiella pneumoniae; MDRO=multi-drug-resistant organism; VRE=vancomycin-resistant Enterococcus.